Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU
Primary Purpose
PACU Length of Stay, Postoperative Nausea, Postoperative Vomiting
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Coffee
Sponsored by
About this trial
This is an interventional health services research trial for PACU Length of Stay focused on measuring PACU length of stay, coffee
Eligibility Criteria
Inclusion criteria:
- 18 years old or older
- Admitted to Bethesda North Minimally Invasive Surgery Center
- Reports to consume at least one cup of coffee a day for at least 5 days in a week
Exclusion Criteria
- History of PONV
- Pre-existing cardiac arrhythmias
- History of seizure disorder
- Pregnant
Sites / Locations
- Bethesda North Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Patients receiving coffee postoperatively
Patients not receiving coffee postoperatively
Arm Description
Patients who self-identify as coffee drinkers and receive coffee postoperatively
Patients who self-identify as coffee drinkers and do not receive coffee postoperatively
Outcomes
Primary Outcome Measures
PACU length of stay
Post-anesthesia Care Unit length of stay
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03712891
Brief Title
Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU
Official Title
Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
October 25, 2018 (Actual)
Primary Completion Date
July 1, 2023 (Actual)
Study Completion Date
October 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
TriHealth Inc.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of the study is to determine if providing coffee to patients who self-identify as coffee drinkers postoperatively will decrease the length of stay in the post-anesthesia care unit (PACU).
Detailed Description
Decreasing the length of stay in PACU for surgical patient is a pertinent outcome. The shorter length of stay can achieve higher patient engagement scores, while simultaneously increasing the productivity of the unit. This is achieved by making more beds available for new patients coming from the operating room (OR). One thought was that coffee would benefit the investigator's patients experience through a number of pathways. Initially, the stimulant effect of coffee would create a more alert patient. A more alert patient is more likely to comprehend home care instruction and be ready for discharge earlier. Coffee is often used as a remedy for morning sickness. Ideally the act of drinking coffee or even smelling the coffee may decrease the occurrence of Post-Operative Nausea and Vomiting (PONV) in investigator's patient population. Finally, patients frequently state that the inability to drink their morning coffee is often more difficult than not being able to eat prior to surgery. By allowing those to drink coffee in PACU this would make the patient feel that they are being cared for on an emotional level, in addition to a physical level.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
PACU Length of Stay, Postoperative Nausea, Postoperative Vomiting, Patient Satisfaction
Keywords
PACU length of stay, coffee
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
168 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Patients receiving coffee postoperatively
Arm Type
Experimental
Arm Description
Patients who self-identify as coffee drinkers and receive coffee postoperatively
Arm Title
Patients not receiving coffee postoperatively
Arm Type
No Intervention
Arm Description
Patients who self-identify as coffee drinkers and do not receive coffee postoperatively
Intervention Type
Dietary Supplement
Intervention Name(s)
Coffee
Intervention Description
Patients will receive coffee in a Styrofoam cup at a temperature of 125 degree Fahrenheit or less. Coffee will be offered to the patient in the PACU once the patient's gag reflex has been restored following their procedure. Volume of estimated coffee consumption will be measured using a sample scale (with a maximum of 300mL of coffee offered)
Primary Outcome Measure Information:
Title
PACU length of stay
Description
Post-anesthesia Care Unit length of stay
Time Frame
6 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria:
18 years old or older
Admitted to Bethesda North Minimally Invasive Surgery Center
Reports to consume at least one cup of coffee a day for at least 5 days in a week
Exclusion Criteria
History of PONV
Pre-existing cardiac arrhythmias
History of seizure disorder
Pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brandon Ballhaus, BSN, RN
Organizational Affiliation
TriHealth Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bethesda North Hospital
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45242
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU
We'll reach out to this number within 24 hrs